Literature DB >> 2998609

Clonal variation in the production of a platelet-derived growth factor-like protein and expression of corresponding receptors in a human malignant glioma.

M Nistér, C H Heldin, B Westermark.   

Abstract

Two cell lines (U-343 MG and U-343 MGa) with different phenotypic characteristics were established from the same human glioblastoma multiforme biopsy. Previous studies have shown that a clonal derivative (Cl 2) of the U-343 MGa line produces a PDGF-like growth factor. In the present investigation glioma PDGF production and 125I-PDGF binding were found to be differently expressed in U-343 MG, U-343 MGa, and U-343 MGa Cl 2 cultures, providing evidence for a clonal variation in these properties. In order to investigate this point further, several clones were derived from low (23 clones) and high (30 clones) passage U-343 MGa cultures, as well as from U-343 MGa Cl 2 cells (30 clones). The clones could be divided into 4 groups according to morphology and growth pattern. A determination of the amount of PDGF receptor competing activity in serum-free conditioned media gave evidence for a clonal variation in the production of glioma PDGF, corresponding to 0-87 ng of authentic PDGF per ml. There was also a considerable range in 125I-PDGF binding (0-44 fmol of tracer bound per 10(6) cells). Scatchard plots performed on two clones confirmed the presence of saturable, high affinity PDGF receptors. High passage cultures were found to give rise to a higher number of high producing clones than did low passage cultures. There appeared to be a negative correlation between production of glioma PDGF and binding of 125I-PDGF, probably due to the receptor blocking activity of the endogenous growth factor. However, the presence of clones, apparently devoid of both glioma PDGF production and 125I-PDGF binding, suggests a true clonal variation in these two parameters. The growth rate in serum-free medium was found to correlate fairly well to the extent of glioma PDGF production. Production of glioma PDGF was found to have a morphological correlate and be most prominent among clones of "immature" looking, tightly growing cells. Clones that had large star-shaped cells with some resemblance to normal glia-like cells in culture were found to have a low production and a high 125I-PDGF binding capacity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2998609

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells.

Authors:  Ai-Hua Gong; Ping Wei; Sicong Zhang; Jun Yao; Ying Yuan; Ai-Dong Zhou; Frederick F Lang; Amy B Heimberger; Ganesh Rao; Suyun Huang
Journal:  Cancer Res       Date:  2015-04-01       Impact factor: 12.701

2.  Effects of growth factors and basement membrane proteins on the phenotype of U-373 MG glioblastoma cells as determined by the expression of intermediate filament proteins.

Authors:  S Sultana; R Zhou; M S Sadagopan; O Skalli
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

3.  Plasma platelet-derived growth factor-B chain is elevated in patients with extensively large brain tumour.

Authors:  M Kurimoto; M Nishijima; Y Hirashima; S Endo; A Takaku
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

4.  Glioma-derived PDGF-related protein presents as 17 kd intracellularly and assembled form induces actin reorganization.

Authors:  T Nakamura; I Takeshita; M Fukui
Journal:  J Neurooncol       Date:  1991-12       Impact factor: 4.130

5.  Coexpression of platelet-derived growth factor (PDGF) B chain and PDGF B-type receptor in human gliomas.

Authors:  A Mauro; A Bulfone; E Turco; D Schiffer
Journal:  Childs Nerv Syst       Date:  1991-12       Impact factor: 1.475

6.  Loss of nucleolar histone chaperone NPM1 triggers rearrangement of heterochromatin and synergizes with a deficiency in DNA methyltransferase DNMT3A to drive ribosomal DNA transcription.

Authors:  Karl Holmberg Olausson; Monica Nistér; Mikael S Lindström
Journal:  J Biol Chem       Date:  2014-10-27       Impact factor: 5.157

7.  An orthotopic glioblastoma animal model suitable for high-throughput screenings.

Authors:  Linda Pudelko; Steven Edwards; Mirela Balan; Daniel Nyqvist; Jonathan Al-Saadi; Johannes Dittmer; Ingrid Almlöf; Thomas Helleday; Lars Bräutigam
Journal:  Neuro Oncol       Date:  2018-10-09       Impact factor: 12.300

8.  mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels.

Authors:  Kaveh M Goudarzi; Monica Nistér; Mikael S Lindström
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

9.  Silencing of ribosomal protein S9 elicits a multitude of cellular responses inhibiting the growth of cancer cells subsequent to p53 activation.

Authors:  Mikael S Lindström; Monica Nistér
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

10.  TM-1 cells from an established human malignant glioma cell line produce PDGF, TGF-alpha, and TGF-beta which cooperatively play a stimulatory role for an autocrine growth promotion.

Authors:  M Kurimoto; S Endo; K Arai; Y Horie; K Nogami; A Takaku
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.